Transition rates from schizotypal disorder to psychotic disorder for first-contact patients included in the OPUS trial. A randomized clinical trial of integrated treatment and standard treatment

Schizophrenia Research

Volumn 83, Issue 1, 2006, Pages 29-40

  Nordentoft, Merete ^a,d   Thorup, Anne ^a   Petersen, Lone ^a   Øhlenschlæger, Johan ^b   Melau, Marianne ^a   Christensen, Torben Østergaard ^c   Krarup, Gertrud ^c   Jørgensen, Per ^c   Jeppesen, Pia ^a  

^a BISPEBJERG HOSPITAL   (Denmark)

^b Sct Hans Hospital   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

^d Rigshospitalet   (Denmark)

Author keywords

Intervention; Prevention; Psychosis; Schizophrenia

Indexed keywords

ADULT; ANTIPSYCHOTIC AGENTS; COMBINED MODALITY THERAPY; COMMUNITY MENTAL HEALTH SERVICES; CONTINUITY OF PATIENT CARE; DELIVERY OF HEALTH CARE, INTEGRATED; DENMARK; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PSYCHOTHERAPY; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOTYPAL PERSONALITY DISORDER;

EID: 33645351683     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2006.01.002     Document Type: Article

References (37)

1. D. Altmann Practical Statistics for Medical Research 1993 Chapman & Hall London
2. N.C. Andreasen, and S. Olsen Negative v positive schizophrenia Arch. Gen. Psychiatry 39 1982 789 794
3. N.C Andreasen, S. Arndt, R. Alliger, D. Miller, and M. Flaum Symptoms of schizophrenia. Methods, meanings, and mechanisms Arch. Gen. Psychiatry 52 1995 341 351
4. S. Arndt, N.C. Andreasen, M. Flaum, D. Miller, and P. Nopoulos A longitudinal study of symptom dimensions in schizophrenia. Prediction and patterns of change Arch. Gen. Psychiatry 52 1995 352 360
5. J.J. Bartko, and W.T. Carpenter Jr. On the methods and theory of reliability J. Nerv. Ment. Dis. 163 1976 307 317
6. H. Hafner, W. Loffler, K. Maurer, M. Hambrecht, and H.W. an der Depression, negative symptoms, social stagnation and social decline in the early course of schizophrenia Acta Psychiatr. Scand. 100 1999 105 118
7. C. Henquet, R. Murray, D. Linszen, and O.J. Van The environment and schizophrenia: the role of cannabis use 1 Schizophr. Bull. 2005
8. P. Jeppesen, L. Petersen, A. Thorup, M.B. Abel, J. Oehlenschlaeger, T.O. Christensen, G. Krarup, R. Hemmingsen, P. Jorgensen, and M. Nordentoft Integrated treatment of first-episode psychosis: effect of treatment on family burden: OPUS trial 2 Br. J. Psychiatry 187 2005 s85 s90
9. P. Jorgensen, M. Nordentoft, M.B. Abel, G. Gouliaev, P. Jeppesen, and P. Kassow Early detection and assertive community treatment of young psychotics: the OPUS study rationale and design of the trial Soc. Psychiatry Psychiatr. Epidemiol. 35 2000 283 287
10. M. lam, S.F. Hung, and E.Y.H. Chen Transition to psychosis in Chinese high risk population Schizophr. Res. 70 suppl, 21 2004 (Ref Type: Abstract)
11. J. Liberman, K.T. Mueser, C.J. Wallace, H.E. Jacobs, and T.A. Eckman Training skills in the psychiatrically disabled: learning coping and competence Schizophr. Bull. 12 1986 631 647
12. R.P. Liberman, C.J. Wallace, G. Blackwell, A. Kopelowicz, J.V. Vaccaro, and J. Mintz Skills training versus psychosocial occupational therapy for persons with persistent schizophrenia Am. J. Psychiatry 155 1998 1087 1091
13. S.R. Marder, W.C. Wirshing, J. Mintz, J. McKenzie, K. Johnston, T.A. Eckman, M. Lebell, K. Zimmerman, and R.P. Liberman Two-year outcome of social skills training and group psychotherapy for outpatients with schizophrenia Am. J. Psychiatry 153 1996 1585 1592
14. M. Marshall, and A. Lockwood Assertive community treatment for those with severe mental disorders Cochrane Library 5 2003
15. M. Marshall, and A. Lockwood Early Intervention for psychosis Cochrane Database Syst. Rev. 2004 (CD004718)
16. W.R. McFarlane Multiple-family groups and psychoeducation in the treatment of schizophrenia Arch. Gen. Psychiatry 52 1995 679 687
17. W.R. McFarlane, E. Lukens, B. Link, R. Dushay, S.A. Deakins, M. Newmark, E.J. Dunne, B. Horen, and J. Toran Multiple-family groups and psychoeducation in the treatment of schizophrenia Arch. Gen. Psychiatry 52 1995 679 687
18. T.H. McGlashan, R.B. Zipursky, D. Perkins, J. Addington, T.J. Miller, S.W. Woods, K.A. Hawkins, R. Hoffman, S. Lindborg, M. Tohen, and A. Breier The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design Schizophr. Res. 61 2003 7 18
19. T.H. McGlashan, R.B. Zipursky, D. Perkins, J. Addington, T. Miller, S.W. Woods, K. Hawkin, R. Hoffmann, M. Tohen, and A. Breier Pharmacotherapy in the prodromal phase of first psychosis: results and implications Schizophr. Res. 70 suppl 2004 6
20. P.D. McGorry "A stitch in time"... the scope for preventive strategies in early psychosis [see comments]. [Review] [64 refs] Eur. Arch. Psychiatry Clin. Neurosci. 248 1998 22 31
21. P.D. McGorry, A.R. Yung, L.J. Phillips, H.P. Yuen, S. Francey, E.M. Cosgrave, D. Germano, J. Bravin, T. McDonald, A. Blair, S. Adlard, and H. Jackson Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms Arch. Gen. Psychiatry 59 2002 921 928
22. T.J. Miller, R.B. Zipursky, D. Perkins, J. Addington, S.W. Woods, K.A. Hawkins, R. Hoffman, A. Preda, I. Epstein, D. Addington, S. Lindborg, E. Marquez, M. Tohen, A. Breier, and T.H. McGlashan The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. II. Baseline characteristics of the "prodromal" sample Schizophr. Res. 61 2003 19 30
23. A.P. Morrison, P. French, L. Walford, S.W. Lewis, A. Kilcommons, J. Green, S. Parker, and R.P. Bentall Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial Br. J. Psychiatry 185 2004 291 297
24. L. Petersen, P. Jeppesen, A. Thorup, M.B. Abel, J. Ohlenschlaeger, T.O. Christensen, G. Krarup, P. Jorgensen, and M. Nordentoft A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness 1 BMJ 331 2005 602
25. S.J. Pocock Clinical Trials. A Practical Approach 1996 John Wiley & Sons Chichester
26. N.A. Rector, M.V. Seeman, and Z.V. Segal Cognitive therapy for schizophrenia: a preliminary randomized controlled trial 1 Schizophr. Res. 63 2003 1 11
27. T. Sensky, D. Turkington, D. Kingdon, J.L. Scott, J. Scott, R. Siddle, M. O'Carroll, and T.R. Barnes A randomized controlled trial of cognitive-behavioral therapy for persistent symptoms in schizophrenia resistant to medication Arch. Gen. Psychiatry 57 2000 165 172
28. A. Skeate, M. Pattersen, and M. Birchwood Transition to psychosis in a high-risk sample: the expirience of ED:IT, Birmingham, UK Schizophr. Res. 70 Suppl, 44 2004 (Ref Type: Abstract)
29. L.I. Stein, and M.A. Test Alternative to mental hospital treatment. I. Conceptual model, treatment program, and clinical evaluation Arch. Gen. Psychiatry 31 1980 37 42
30. A. Thorup, L. Petersen, P. Jeppesen, J. Ohlenschlaeger, T. Christensen, G. Krarup, P. Jorgensen, and M. Nordentoft Integrated treatment ameliorates negative symptoms in first episode psychosis-results from the Danish OPUS trial 2 Schizophr. Res. 79 2005 95 105
31. S.W. Woods, A. Breier, R.B. Zipursky, D.O. Perkins, J. Addington, T.J. Miller, K.A. Hawkins, E. Marquez, S.R. Lindborg, M. Tohen, and T.H. McGlashan Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome Biol. Psychiatry 54 2003 453 464
32. World Health Organization The ICD-10 Classification of Mental and Behavioural Disorders. Clinical descriptions and diagnostic guidelines 1992 WHO Geneva
33. World Health Organization The ICD-10 Classification of Mental and Behavioural Disorders. Diagnostic Criteria for Research 1993 World Health Organization Geneva
34. World Health Organization Schedule for Clinical Assessment in Neuropsychiatry, version 2.1. Division of Mental Health. Present State Examination 1998 World Health Organization Geneva
35. A.R. Yung, and P.D. McGorry Is pre-psychotic intervention realistic in schizophrenia and related disorders? [see comments]. [Review] [21 refs] Aust. N. Z. J. Psychiatry 31 1997 799 805
36. A.R. Yung, L.J. Phillips, P.D. McGorry, C.A. McFarlane, S. Francey, S. Harrigan, G.C. Patton, and H.J. Jackson Prediction of psychosis. A step towards indicated prevention of schizophrenia Br. J. Psychiatr., Suppl. 172 1998 14 20
37. A.R. Yung, L.J. Phillips, H.P. Yuen, S.M. Francey, C.A. McFarlane, M. Hallgren, and P.D. McGorry Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group Schizophr. Res. 60 2003 21 32